TOPICAL CARBONIC ANHYDRASE INHIBITORS CLOSING BILATERAL SECONDARY MACULAR HOLES AND A REVIEW OF LITERATURE
- PMID: 37582334
- DOI: 10.1097/ICB.0000000000001469
TOPICAL CARBONIC ANHYDRASE INHIBITORS CLOSING BILATERAL SECONDARY MACULAR HOLES AND A REVIEW OF LITERATURE
Abstract
Purpose: To present a rare occurrence of bilateral macular hole secondary to vitrectomy that was successfully treated with topical carbonic anhydrase inhibitors and to review the literature for this phenomenon.
Methods: Monthly clinical examination and optical coherence tomography was conducted before and after eight weeks of topical 2% dorzolamide administered twice a day.
Results: A 62-year-old man who had bilateral giant retinal tears which were repaired with vitrectomy subsequently presented with bilateral small macular holes of size 74 and 78 μm. The patient was trialed on 2% topical dorzolamide twice a day and reviewed monthly with optical coherence tomography scans. Macular hole closure was identified after four weeks of topical treatment.
Conclusion: Clinical improvement with conservative measures suggests a potential first-line approach to the treatment of macular holes avoiding surgery and its risk profile. We also present a review of the literature regarding macular holes treated with topical carbonic anhydrase inhibitors and its mechanism of action in treating macular holes.
Keywords: carbonic anhydrase inhibitors; dorzolamide; macular hole.
Similar articles
-
Topical dorzolamide for macular holes: A randomised, double-blind, placebo-controlled trial.Clin Exp Ophthalmol. 2024 Nov;52(8):870-879. doi: 10.1111/ceo.14432. Epub 2024 Aug 15. Clin Exp Ophthalmol. 2024. PMID: 39145570 Clinical Trial.
-
Topical Aqueous Suppression and Closure of Idiopathic Full-Thickness Macular Holes.Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):e38-e43. doi: 10.3928/23258160-20190129-17. Ophthalmic Surg Lasers Imaging Retina. 2019. PMID: 30768228
-
POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.Retin Cases Brief Rep. 2018 Winter;12(1):75-79. doi: 10.1097/ICB.0000000000000433. Retin Cases Brief Rep. 2018. PMID: 27749791
-
Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.Surv Ophthalmol. 1997 Sep-Oct;42(2):137-51. doi: 10.1016/s0039-6257(97)00053-2. Surv Ophthalmol. 1997. PMID: 9381367 Review.
-
Topical carbonic anhydrase inhibitors.Curr Opin Ophthalmol. 1997 Apr;8(2):2-6. doi: 10.1097/00055735-199704000-00002. Curr Opin Ophthalmol. 1997. PMID: 10168353 Review.
References
-
- Kang HG, Han JY, Choi EY, et al. Clinical characteristics, risk factors, and surgical outcomes of secondary macular hole after vitrectomy. Sci Rep 2019;9:19535.
-
- Lee SH, Park KH, Kim JH, et al. Secondary macular hole formation after vitrectomy. Retina 2010;30:1072–1077.
-
- Tornambe PE. Macular hole genesis: the hydration theory. Retina 2003;23:421–424.
-
- Zhao PP, Wang S, Liu N, et al. A review of surgical outcomes and advances for macular holes. J Ophthalmol 2018;2018:1–10.
-
- Lam D, Srour M, Semoun O, et al. Resolution of a macular hole complicating a pseudophakic macular edema with nonsurgical treatment. RETINAL Cases Brief Rep 2018;12:131–135.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources